| Prev Close: | 37.38 |
|---|---|
| Open: | 36.95 |
| Bid: | 36.99 x 100 |
| Ask: | 37.04 x 100 |
| 1y Target Est: | 35.23 |
| Beta: | 0.34 |
| Next Earnings Date: | 5-Aug-13 |
| Day's Range: | 35.73 - 37.10 |
|---|---|
| 52wk Range: | 25.25 - 37.64 |
| Volume: | 113,944 |
| Avg Vol (3m): | 222,248 |
| Market Cap: | 1.12B |
| P/E (ttm): | 172.28 |
| EPS (ttm): | 0.22 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 6 Ways You Can Profit From Molecular Diagnosticsat Seeking Alpha(Wed May 22)
- Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual MeetingPR Newswire(Tue May 21)
- Genomic Health Director Buys More Than 52K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Fri May 17)
- In Insider Trading, Harbinger Buys Spectrum Brands Stock for 11th Time Since April 9Minyanville(Fri May 17)
- Hecla Mining CEO Buys 150K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Thu May 16)
- The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis PharmaceuticalsZacks(Thu May 16)
- Genomic Health's New Prostate Test May Extend The Stock's Upward Climbat Seeking Alpha(Wed May 15)
- New cancer tools allow patients to reconsider chemoat Reuters(Wed May 15)
- Much Awaited Test Launch by GenomicZacks(Wed May 15)
- 5 Stocks Insiders Love Right Nowat TheStreet(Wed May 15)
- An Insider Sells Major Stake of General Growth Properties While Directors at Genomic Health and US Steel Buy StockMinyanville(Wed May 15)
- U.S. Steel Director Buys More Than 72K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Wed May 15)
- 3 Disruptive Technologies That Could Slash Health-Care Costsat Motley Fool(Tue May 14)
- Myriad Genetics climbs after Jolie reveals genetic testingat theflyonthewall.com(Tue May 14)
- Genomic Gains Coverage for DCISZacks(Mon May 13)
Press Releases
- Genomic Health Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology (ASCO) Annual MeetingPR Newswire(Tue May 21)
- Genomic Health Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test to Include Ductal Carcinoma in Situ (DCIS) DiagnosisPR Newswire(Fri May 10)
- Genomic Health Announces Availability of Oncotype DX® Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive TreatmentsPR Newswire(Wed May 8)
Must Read
- TSX, U.S. indexes fall as world markets plunge on Chinese manufacturing dataThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- House approves student loan rates linked to financial markets despite a veto threatThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Mobilicity debtholders approve plan to sell company to Telus for $380 millionThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Ally to pay $2.1 billion to settle claims tied to ResCapReuters(1969-12-31T18:59:59GMT-05:00)
- Obama's Commerce pick Pritzker faces scrutiny over ties to failed thrift, offshore tax havenThe Canadian Press(1969-12-31T18:59:59GMT-05:00)